Pharmacology and Pharmaceutical Sciences articles for Harvard University, United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 79

Article ‘Count’ for Pharmacology and Pharmaceutical Sciences.

Journal Count Share
1 0.80
Injectable Microparticle-Nanoliposome Hydrogel for Extended Release of Small Hydrophilic Molecules 0.80
1 0.08
Gastrointestinal distribution of engineered biodegradable urease-powered nanomotors 0.08
2 0.37
Spleen-Targeting Biomimetic Hybrid Nanocarriers for Systemic Immune Reprogramming in Colitis: RBC Membrane Vesicle-Fused Lipid Nanoparticles 0.27
Four‐Pronged Nanomotor Strategy Achieves Efficient TNBC Treatment via Synergistic Chemo‐Photothermal‐Immune Therapy 0.10
3 1.97
High Concentration Antibody Formulations Enabled via Thermostable Ionic Liquids 0.92
Orally Administered Nanoparticle Coacervate for Therapeutic Coating of Full Gastrointestinal Tract 0.05
Enhanced Control of Liposomal Drug Release by Drug–Aptamer Complexes 1.00
1 0.64
Sensory-selective peripheral and neuraxial nerve blockade with 2',6'-pipecolylxylidine. 0.64
4 1.19
Precise Spatiotemporal Control of Sensory Nerve Blockade via Light-Triggered Click-Release Uncaging of 2′,6′-Pipecoloxylidide 0.10
Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation 0.80
Surface Avidity of Anionic Polypeptide Coatings on Layer‐by‐Layer Nanoparticles Target Cancer‐Associated Amino Acid Transporters 0.04
Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders 0.25
2 1.01
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes. 0.79
Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023) : A Cross-Sectional Study. 0.22
1 0.80
Does Missing Medication Acutely Change Seizure Risk? A Prospective Study 0.80
1 0.10
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis 0.10
2 0.15
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis 0.03
Associations of specific pesticides and incident rheumatoid arthritis among female spouses in the Agricultural Health Study 0.13
1 0.83
A context-augmented large language model for accurate precision oncology medicine recommendations 0.83
1 0.04
Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protein Degradation Approaches 0.04
1 0.11
A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients with Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial. 0.11
1 0.29
Hypertension in a Randomized Trial of Dolutegravir- Versus Efavirenz-Based Antiretroviral Therapy in Pregnant and Postpartum Women with HIV 0.29
1 0.04
Effect of Comprehensive Medication Management on Mortality in Critically Ill Patients. 0.04
3 1.01
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes. 0.02
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes. 0.94
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. 0.04
2 0.40
Time-Varying Exposure to Element Mixtures and Children’s Cognition at 5 Years of Age: Findings from the New Hampshire Birth Cohort Study 0.20
Time-varying exposure to element mixtures and children's cognition at 5 years of age: findings from the New Hampshire Birth Cohort Study. 0.20
2 0.71
Prenatal and early postnatal lead exposure and later adulthood BMI: The Saint Louis Baby Tooth – Later Life Health Study 0.64
Extracellular vesicle microRNAs as an epigenetic biosignature of arsenic-associated diabetes in the Strong Heart Study 0.08
1 0.13
Oral Exposure of Arsenic-Contaminated Soils Triggers Hepatic Ferroptosis via Iron Dysregulation and Glutathione Metabolism Disruption: From Bioavailability to Mechanisms 0.13
1 0.89
Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity 0.89
1 0.38
Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysis 0.38
1 0.33
Fine particulate matter exposure and sperm DNA fragmentation in US men: a spatial cross-sectional study 0.33
1 0.25
FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program 0.25
4 1.85
Electronic Health Record Intervention and Deprescribing for Older Adults 0.72
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation 0.91
Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children 0.14
Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder 0.08
1 0.80
Enhancing Osteosarcoma Survival Predictions: A Comparative Study of a Multicomponent-Model Machine Learning Approach Integrating SEER and NCDB Data Sets Versus Conventional Single-Data-Set Modeling. 0.80
1 0.04
Diazoxide Choline Extended-release Tablets in Prader-Willi Syndrome: A Randomized, Double-blind, Withdrawal Period Study 0.04
1 0.11
Serum- and glucocorticoid-induced kinase 3 orchestrates glucocorticoid signaling to facilitate chromatin remodeling during murine adipogenesis 0.11
1 0.17
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s 0.17
5 2.37
In Situ Transformable Photothermal Targeting Chimeras for Spatiotemporally Controllable Protein Degradation and Combination Immunotherapy for Cancer 0.08
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA) 0.54
Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes 0.36
Computationally Designed Nanobinders as Affinity Ligands in Diagnostic and Therapeutic Applications 0.71
Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes 0.67
1 0.18
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy 0.18
3 0.39
Prevalence and Duration of Potential Drug–Drug Interactions Among scpUS/scp Nursing Home Residents, 2018–2020 0.20
Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People 0.03
Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity 0.17
1 0.76
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation 0.76
1 0.06
Manufacturing-aware generative models enable petascale synthesis of designed DNA 0.06
2 1.35
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma 0.99
Charged molecular glue discovery enabled by targeted degron display 0.36
5 1.17
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity 0.25
Counting cells can accurately predict small-molecule bioactivity benchmarks 0.16
Injectable hydrogels for osteomyelitis treatment induce metabolic reprogramming for protection against reinfection 0.08
Bioresorbable RFID capsule for assessing medication adherence 0.21
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis 0.46
1 0.87
Real-time dynamic polygenic prediction for streaming data 0.87
1 0.31
Lifetime Benefits of Comprehensive Medical Therapy in Heart Failure with Mildly Reduced or Preserved Ejection Fraction 0.31
1 0.21
Hypervariable loop profiling decodes sequence determinants of antibody stability 0.21
1 0.56
Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study 0.56
5 3.12
Rebinding drives cellular retention of small-molecule drugs with abundant targets 1.00
Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human VH1-2-rearranging mouse models 0.43
Mechanical performance of hybrid polymer–lipid vesicles with leaflet asymmetry engineered using microfluidics 0.55
Extended local anesthesia enabled by flavonoid permeation enhancers 0.89
A multivalent nanobody–drug conjugate to prevent and treat influenza virus infections 0.25
1 0.03
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes 0.03
2 0.19
Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM 0.08
Developmental Pb exposure increases rate of forgetting on a delayed matching-to-sample task among Mexican children 0.11
2 0.92
Polymeric rapamycin nanoparticles encapsulating ponatinib cause regression of venous malformations in mice 0.80
Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion 0.12
1 0.03
Benzodiazepine or Z-hypnotic use during pregnancy and risk of psychiatric disorders in children: population based cohort study 0.03
1 0.10
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial 0.10
2 0.08
Azithromycin for Preschoolers with Wheezing in the Emergency Department 0.07
Ivermectin to Control Malaria — A Cluster-Randomized Trial 0.01

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.